Seller: Immucor
Buyer: Werfen
Announced: November 2022
Deal Value: $2B
U.S.-based Immucor, developer of transfusion and transplantation diagnostics systems, was purchased by Spain-based specialized diagnostic instruments provider, Werfen for $2B.
Seller: Signify Health
Buyer: CVS Health
Announced: September 2022
Deal Value: $7.5B
Signify Health, health assessment, clinical workflow, and logistics SaaS, was bought by CVS Health for $7.5B.
Seller: Parata
Buyer: BD
Announced: June 2022
Deal Value: $1.5B
EV/S Multiple: 6.9x
Pharmacy automation solutions provider, Parata Systems, was bought by BD for $1.5B at 6.9 times revenue The acquisition will allow BD to enter a new high-growth pharmacy automation space.
Seller: Covetrus
Buyer: TPG Capital/Clayton Dubilier & Rice
Announced: May 2022
Deal Value: $2.9B
An animal-healthcare management SaaS, Covetrus was acquired by TPG Capital/Clayton Dubilier & Rice, for $2.9B.
Seller: Change Healthcare
Buyer: TPG Capital
Announced: April 2022
Deal Value: $2.2B
Seller: Informa Pharma
Buyer: Warburg Pincus
Announced: February 2022
Deal Value: $2.3B
Informa’s clinical trial intelligence SaaS, Pharma Intelligence was purchased by Warburg Pincus, for $2.3B
Seller: Cloudmed
Buyer: R1 RCM
Announced: January 2022
Deal Value: $3.2B
EV/S Multiple: 5.4x
Seller: Odin Vision
Buyer: Olympus
Announced: December 2022
Deal Value: $40.2M
EV/S Multiple: 28.9x
AI-based endoscopy detection and diagnosis SaaS Odin Vision, out of the U.K., was acquired by Olympus Corporation for $40.2M at 28.9 times revenue to complement Olympus’ Digital Endosuite vision, transforming clinical and procedural workflows.
Seller: MedAware
Buyer: Biomed
Announced: September 2022
Deal Value: $18M
MedAware, an AI-powered medical data analytics SaaS, was picked up by Biomed for $18M to optimize and expand Biomed’s drug development in finding treatment and prevention approaches for neurodegenerative diseases.
Seller: Rx Savings Solutions
Buyer: McKesson
Announced: September 2022
Deal Value: $600M
Prescription price transparency and benefit analytics SaaS, Rx Savings Solutions was acquired by McKesson for $600M to accelerate McKesson’s growth in the biopharma services market as well as in advanced health outcomes for all.